![James Oliviero](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Oliviero
Direktor/Vorstandsmitglied bei
NUVECTIS PHARMA, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Mr. James F.
Oliviero is an Independent Director at Nuvectis Pharma, Inc. He is on the Board of Directors at Nuvectis Pharma, Inc. Mr. Oliviero was previously employed as a President, Chief Executive Officer & Director by Checkpoint Therapeutics, Inc., a Chief Financial Officer & Treasurer by Keryx Biopharmaceuticals, Inc., and a Finance Director by ACCESS Oncology, Inc. He received his undergraduate degree from Goizueta Business School-Emory.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.06.2026 | 122’828 ( 0.46% ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von James Oliviero
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVECTIS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.07.2021 |
Ehemalige bekannte Positionen von James Oliviero
| Unternehmen | Position | Ende |
|---|---|---|
| CHECKPOINT THERAPEUTICS, INC. | Vorstandsvorsitzender | 30.05.2025 |
| KERYX BIOPHARMACEUTICALS | Finanzdirektor/CFO | 01.09.2015 |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Finanzdirektor/CFO | 01.05.2003 |
Ausbildung von James Oliviero
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkpoint Therapeutics, Inc.
 Checkpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
